The LyP-1-modified nanosystem containingendostatin showed improved effectiveness in fighting against KYSE-30cells by directly attacking tumor lymphatics, causing nucleus rupture,degrading mitochondria, reducing cell growth and movement, and inhibitingVEGF-C and MMP2 expression. This evidence concerns the gene PTPN22 and neoplasm.